913296-07-8

Basic information

• Product Name: 4-(6-(2-(3,4,5-Trifluorophenyl)-4-(trifluoromethyl)phenyl)pyrimidin-4-ylamino)-2,3-dihydro-1H-inden-2-ol
• Synonyms: 4-(6-(2-(3,4,5-Trifluorophenyl)-4-(trifluoromethyl)phenyl)pyrimidin-4-ylamino)-2,3-dihydro-1H-inden-2-ol
• CAS NO: 913296-07-8
• Molecular Weight: 501.431
• Mol File: 913296-07-8.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 4-(6-(2-(3,4,5-Trifluorophenyl)-4-(trifluoromethyl)phenyl)pyrimidin-4-ylamino)-2,3-dihydro-1H-inden-2-ol(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(6-(2-(3,4,5-Trifluorophenyl)-4-(trifluoromethyl)phenyl)pyrimidin-4-ylamino)-2,3-dihydro-1H-inden-2-ol(913296-07-8)
• EPA Substance Registry System: 4-(6-(2-(3,4,5-Trifluorophenyl)-4-(trifluoromethyl)phenyl)pyrimidin-4-ylamino)-2,3-dihydro-1H-inden-2-ol(913296-07-8)

Safety Data

• Hazardous Substances Data: 913296-07-8(Hazardous Substances Data)

Upstream product

• 913296-06-7 4-(6-(2-iodo-4-(trifluoromethyl)phenyl)pyrimidin-4-ylamino)-2,3-dihydro-1H-inden-2-ol 
• 143418-49-9 3,4,5-trifluorophenylboronic acid 

Relevant articles and documents

Vanilloid receptor ligands and their use in treatments

Compounds having the general structure and compositions containing them, for the treatment of acute, inflammatory and neuropathic pain, dental pain, general headache, migraine, cluster headache, mixed-vascular and non-vascular syndromes, tension headache, general inflammation, arthritis, rheumatic diseases, osteoarthritis, inflammatory bowel disorders, inflammatory eye disorders, inflammatory or unstable bladder disorders, psoriasis, skin complaints with inflammatory components, chronic inflammatory conditions, inflammatory pain and associated hyperalgesia and allodynia, neuropathic pain and associated hyperalgesia and allodynia, diabetic neuropathy pain, causalgia, sympathetically maintained pain, deafferentation syndromes, asthma, epithelial tissue damage or dysfunction, herpes simplex, disturbances of visceral motility at respiratory, genitourinary, gastrointestinal or vascular regions, wounds, burns, allergic skin reactions, pruritus, vitiligo, general gastrointestinal disorders, gastric ulceration, duodenal ulcers, diarrhea, gastric lesions induced by necrotising agents, hair growth, vasomotor or allergic rhinitis, bronchial disorders or bladder disorders.